New antibody therapy may reverse diabetic retinopathy and other eye conditions
Education, dementia, . . . and other stories
10 June 2021COVID-19 lab leak theory highlights glaring lack of global biosecurity regulation
10 June 2021New antibody therapy may reverse diabetic retinopathy and other eye conditions
The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy—a protein to treat disease. A century later, a new biologic therapy also developed by researchers at U of T has potential to reverse a common complication of diabetes.
